Funding for this research was provided by:
National Institute on Aging (P01AG019724, K24AG053435, K23AG045289, U01 AG052943, R01AG034570, K08AG052648, R01AG038791, K23AG055688, P50-AG023501)
National Institute of Neurological Disorders and Stroke (R01NS050915, U54NS092089)
National Institute on Deafness and Other Communication Disorders (K24DC015544)
Michael J. Fox Foundation for Parkinson's Research
Association for Frontotemporal Degeneration
Fondation pour la Recherche Médicale
Alzheimer's Association (AARF-16-443577)
Bluefield Project to Cure FTD
Consortium for Frontotemporal Dementia Research
State of California DHS Alzheimer's Disease Research Center of California (04-33516)
State of California DHS Alzheimer’s Disease Research Center of California (DHS04-33516)
John Douglas French Alzheimer's Foundation
Received: 2 July 2018
Accepted: 17 January 2019
First Online: 31 January 2019
Ethics approval and consent to participate
: Informed consent was obtained from all subjects or their surrogate decision-makers, and the UCSF, University of California Berkeley (UCB) and Lawrence Berkeley National Laboratory (LBNL) Institutional Review Boards for human research approved the study.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.